Susquehanna International Group’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-12,900
| Closed | -$423K | – | 14858 |
|
|
2022
Q2 | $423K | Buy |
+12,900
| New | +$408K | ﹤0.01% | 8687 |
|
|
2020
Q3 | – | Sell |
-46,300
| Closed | -$1.01M | – | 11386 |
|
|
2020
Q2 | $1.01M | Sell |
46,300
-500
| -1% | -$11.4K | ﹤0.01% | 5900 |
|
|
2020
Q1 | $1.08M | Buy |
46,800
+36,300
| +346% | +$1.06M | ﹤0.01% | 5226 |
|
|
2019
Q4 | $346K | Sell |
10,500
-14,500
| -58% | -$465K | ﹤0.01% | 7737 |
|
|
2019
Q3 | $796K | Buy |
25,000
+8,800
| +54% | +$256K | ﹤0.01% | 6201 |
|
|
2019
Q2 | $416K | Sell |
16,200
-1,200
| -7% | -$30.6K | ﹤0.01% | 7653 |
|
|
2019
Q1 | $442K | Sell |
17,400
-14,400
| -45% | -$430K | ﹤0.01% | 6509 |
|
|
2018
Q4 | $1.08M | Buy |
31,800
+1,600
| +5% | +$52K | ﹤0.01% | 4528 |
|
|
2018
Q3 | $1.08M | Sell |
30,200
-9,400
| -24% | -$332K | ﹤0.01% | 5072 |
|
|
2018
Q2 | $1.37M | Sell |
39,600
-58,700
| -60% | -$2.06M | ﹤0.01% | 4730 |
|
|
2018
Q1 | $3.31M | Sell |
98,300
-32,700
| -25% | -$1.03M | ﹤0.01% | 3107 |
|
|
2017
Q4 | $5M | Buy |
131,000
+7,300
| +6% | +$291K | ﹤0.01% | 2537 |
|
|
2017
Q3 | $4.64M | Buy |
123,700
+60,300
| +95% | +$2.13M | ﹤0.01% | 2589 |
|
|
2017
Q2 | $2.37M | Buy |
63,400
+27,800
| +78% | +$1M | ﹤0.01% | 3603 |
|
|
2017
Q1 | $1.4M | Buy |
35,600
+28,500
| +401% | +$1.07M | ﹤0.01% | 4428 |
|
|
2016
Q4 | $247K | Sell |
7,100
-30,400
| -81% | -$1.19M | ﹤0.01% | 8309 |
|
|
2016
Q3 | $1.47M | Sell |
37,500
-3,900
| -9% | -$156K | ﹤0.01% | 4084 |
|
|
2016
Q2 | $1.56M | Buy |
41,400
+17,600
| +74% | +$589K | ﹤0.01% | 4006 |
|
|
2016
Q1 | $915K | Buy |
23,800
+8,100
| +52% | +$302K | ﹤0.01% | 5272 |
|
|
2015
Q4 | $754K | Buy |
15,700
+1,600
| +11% | +$74.1K | ﹤0.01% | 5990 |
|
|
2015
Q3 | $556K | Sell |
14,100
-11,600
| -45% | -$493K | ﹤0.01% | 6914 |
|
|
2015
Q2 | $1.09M | Buy |
25,700
+18,700
| +267% | +$745K | ﹤0.01% | 6029 |
|
|
2015
Q1 | $276K | Sell |
7,000
-41,900
| -86% | -$1.55M | ﹤0.01% | 8125 |
|
|
2014
Q4 | $1.76M | Sell |
48,900
-77,500
| -61% | -$2.6M | ﹤0.01% | 4700 |
|
|
2014
Q3 | $3.73M | Buy |
126,400
+6,400
| +5% | +$177K | ﹤0.01% | 3487 |
|
|
2014
Q2 | $3.02M | Buy |
120,000
+67,500
| +129% | +$1.67M | ﹤0.01% | 3913 |
|
|
2014
Q1 | $1.35M | Buy |
52,500
+36,600
| +230% | +$922K | ﹤0.01% | 4980 |
|
|
2013
Q4 | $358K | Buy |
+15,900
| New | +$307K | ﹤0.01% | 7288 |
|
Other funds holding NTUS
Susquehanna International Group's NTUS Position: Q1 2022 in Review
Susquehanna International Group sold out of Natus Medical Inc (NTUS) in Q1 2022, closing a stake of 9,576 shares — an estimated $227K sold.
Susquehanna International Group first reported a position in NTUS in Q4 2013 and held it in 24 quarters. The position peaked at $5.19M in Q1 2014. 172 funds tracked by Wall St. Rank hold NTUS as of Q1 2022.
- Susquehanna International Group reported no remaining Natus Medical Inc position as of Q1 2022 after selling out during the quarter.
- Susquehanna International Group sold 9,576 Natus Medical Inc shares in Q1 2022, an estimated $227K.
- Susquehanna International Group first reported a position in Natus Medical Inc in Q4 2013 and held it in 24 quarters.
- Susquehanna International Group's Natus Medical Inc position peaked at $5.19M in Q1 2014.
- 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2022.
Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.